Amendment of Statement of Principles concerning ischaemic heart disease No. 96 of 2010

Administered by Department of Veterans' Affairs

Legislation au F2010L02852 Not in force Legislative Instrument

Legislation content

 

 

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 96 OF 2010

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) & (8) of the Veterans’ Entitlements Act 1986 (the VEA) Statement of Principles Instrument No. 96 of 2010.

 

2.             This Instrument amends Statement of Principles Instrument No. 89 of 2007, as amended by Instrument No. 43 of 2009 concerning ischaemic heart disease, by:

 

  • Inserting new factors 6(va) & 6(rra) concerning 'inhaling, ingesting or having cutaneous contact with the phenoxy acid herbicides 2,4-dichlorophenoxyacetic acid (2,4-D) or 2,4,5-trichlorophenoxyacetic acid (2,4,5-T)';
  • Inserting new factors 6(vb) & 6(rrb) concerning 'inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)';
  • Inserting new factors 6(vc) & 6(rrc) concerning 'having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester'; and
  • Inserting new definitions for 'acute cholinergic poisoning', 'an organophosphorus ester' and 'inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)' in clause 9.

 

3.             This Instrument also specifies a date of effect for the amendment in accordance with sub-section 12(1)(a) of the Legislative Instruments Act 2003.

 

4.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to ischaemic heart disease in the Government Notices Gazette of 4 November 2009, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

 

5.             The determining of this Instrument finalises the investigation in relation to ischaemic heart disease as advertised in the Government Notices Gazette of 4 November 2009.

 

6.             A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

 

The Registrar

Repatriation Medical Authority Secretariat

GPO Box 1014

BRISBANE    QLD    4001

Overview

The Veterans’ Entitlements Act 1986, as amended by the Repatriation Medical Authority Instrument No. 96 of 2010, was enacted to address the gaps in existing legislation concerning ischaemic heart disease among veterans. The problem it aimed to address was the need for updated medical statements to include the effects of exposure to certain chemicals during military service, specifically the phenoxy acid herbicides 2,4-D and 2,4,5-T, a chemical agent contaminated by TCDD, and organophosphorus esters. This legislative instrument was developed by the Repatriation Medical Authority, which operates under the authority of the Veterans’ Entitlements Act. The policy objective behind this amendment is to ensure that veterans who developed ischaemic heart disease due to exposure to these specific agents during their service are recognised and provided with the appropriate entitlements and compensation.

Scope and Application

The Repatriation Medical Authority Instrument No. 96 of 2010 amends the Statement of Principles Instrument No. 89 of 2007 concerning ischaemic heart disease, under the Veterans’ Entitlements Act 1986. This instrument applies to veterans and service personnel who have suffered from ischaemic heart disease due to specific exposures during their service. The exposures include inhaling, ingesting, or having cutaneous contact with the phenoxy acid herbicides 2,4-D and 2,4,5-T, exposure to a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD), and experiencing acute cholinergic poisoning from organophosphorus esters. The amendments specify new factors and definitions relevant to these conditions, which are intended to provide clearer criteria for entitlement to benefits under the Military Rehabilitation and Compensation Act 2004. The instrument's application extends to Commonwealth jurisdiction, and it is part of a legislative framework that may be further detailed through subordinate instruments.

Key Provisions

The Repatriation Medical Authority has established Statement of Principles Instrument No. 96 of 2010, amending Statement of Principles Instrument No. 89 of 2007, as modified by Instrument No. 43 of 2009, under the authority granted by subsection 196B(2) and (8) of the Veterans’ Entitlements Act 1986 (VEA). This amendment focuses on ischaemic heart disease, introducing new factors that link this condition to specific exposures during military service (subsection 196B(2)). These new factors include exposure to phenoxy acid herbicides such as 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), exposure to chemical agents contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD), and episodes of acute cholinergic poisoning from organophosphorus esters (subsection 196B(8)). Additionally, new definitions are provided for terms such as "acute cholinergic poisoning," "an organophosphorus ester," and "inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)" in clause 9. The obligations imposed by this Instrument on the parties governed by the VEA and the Military Rehabilitation and Compensation Act 2004 include ensuring that claims related to ischaemic heart disease consider the new exposure factors and definitions. The Authority must also provide information and documentation to relevant parties, including the Repatriation Commission and other organisations or individuals with expertise or vested interest in veterans' health, as specified in section 196E of the VEA. This includes making available a list of references related to the condition upon written request. The Authority's role involves facilitating the investigation and finalising it by issuing the Instrument, which was advertised in the Government Notices Gazette on 4 November 2009, and inviting submissions from relevant stakeholders. Failure to comply with the provisions of this Instrument may result in various legal consequences. Although specific offences and penalties are not detailed in the text, breaches of the VEA or the Military Rehabilitation and Compensation Act 2004 can lead to civil or criminal penalties. The maximum penalties for such breaches can vary depending on the nature and severity of the offence. Typically, penalties may include fines and, in more severe cases, imprisonment. Additionally, parties found to be in breach of their obligations under the Acts may face legal action, including injunctions or orders to rectify the non-compliance. It is crucial for all involved parties to adhere to the requirements set out in the Instrument to avoid these potential consequences.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Prohibited Conduct

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.